Australian Pharmaceutical Industries Ltd operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Australian Pharmaceutical Industries Ltd with three other drug stores in Australasia: Sigma Healthcare Ltd (2017 sales of 4.44 billion Australian Dollars [US$3.46 billion] of which 100% was Healthcare), Medical Developments International Ltd (18.36 million Australian Dollars [US$14.29 million] of which 60% was Pharmaceuticals), and Ebos Group Limited which is based in New Zealand (7.63 billion New Zealand Dollars [US$5.58 billion] of which 94% was Healthcare).

Sales Analysis. During the year ended August of 2017, sales at Australian Pharmaceutical Industries Ltd were A$4.07 billion (US$3.17 billion). This is an increase of 5.8% versus 2016, when the company's sales were A$3.84 billion. This was the fourth straight year of sales growth at Australian Pharmaceutical Industries Ltd. Sales of Operating-Australia saw an increase of 5.8% in 2017, from A$3.79 billion to A$4.02 billion. Not all segments of Australian Pharmaceutical Industries Ltd experienced an increase in sales in 2017: sales of Operating-New Zealand fell 5.3% to A$50.65 million. (However, this segment's sales were only a very small portion of the company's overall sales).